William Blair & Company’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
William Blair & Company's HALO Position: Q2 2026 in Review
William Blair & Company increased its Halozyme (HALO) stake by 4.5% in Q2 2026, buying an estimated $31K and bringing the position to 10,658 shares worth $834K. The position accounts for ﹤0.01% of the portfolio, ranked #1047.
William Blair & Company first reported a position in HALO in Q2 2013 and has held it in 24 quarters since. The position peaked at $1.03M in Q4 2020. 672 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- William Blair & Company held 10,658 shares of Halozyme worth $834K as of Q2 2026.
- William Blair & Company bought 455 Halozyme shares in Q2 2026, an estimated $31K.
- Halozyme made up ﹤0.01% of William Blair & Company's portfolio in Q2 2026, its #1047 holding.
- William Blair & Company first reported a position in Halozyme in Q2 2013 and has held it in 24 quarters since.
- William Blair & Company's Halozyme position peaked at $1.03M in Q4 2020.
- 672 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on William Blair & Company's 13F filing for Q2 2026, filed 11 Aug 2026.